81 Ahmedabad Hospitals delisted, AHNA issues legal notice to Tata AIG

Ahmedabad: The Ahmedabad Hospitals and Nursing Homes Association (AHNA) has issued a legal notice to Tata AIG Gen Insurance Co for arbitrarily “delisting/excluding” 81 hospitals in the city without following the proper procedure. 

The association has warned that if the insurer does not reverse the delisting decision, the association, which represents approximately 1,000 member hospitals, will initiate a boycott of Tata AIG General Insurance Co. This would result in the unavailability of cashless or reimbursement facilities for any Tata AIG policyholders starting from July 15th.

This comes after the insurance firm allegedly published the delisted hospital’s names on its website without giving any valid reasons or an opportunity for the delisted hospitals to defend themselves.

Also read- Apollo Cancer Centre Launches First Robotic And Stereotactic Therapy Education Centre

Earlier, a formal letter was sent but the insurance firm did not respond to the letter following which the association sent a legal notice in this regard. AHNA vice-president Dr Viren Shah termed the insurer’s move “against the principle of natural justice”.

As per The Indian Express news report, AHNA president Dr Bharat Gadhavi said, “When AHNA and hospital representatives tried to contact the insurance company officials, they gave irresponsible answers. A letter sent by AHNA did not elicit any response from Tata AIG Insurance and hence, it was decided to send a legal notice to the company. The list put up by Tata AIG has been replicated by some other private insurance companies as well and they, too, have kept these 81 hospitals in a ‘delisted/excluded’ list.”

Further, AHNA representatives informed that they have received complaints from patients and member hospitals that some of the insurers are informing their patients not to take treatment in hospitals having less than 15 beds. The association has decided to take legal action against such firms.

Also read- PCMC Fire Department Issues Notice To Private Hospitals On Fire Safety

Powered by WPeMatico

From Next year, Motilal Nehru Medical College MBBS Graduates to Receive Degrees from Atal Bihari Vajpayee Medical University

Uttar Pradesh- From next year, MBBS students graduating from the Motilal Nehru Medical College (MLNMC), Prayagraj, will get degrees from Atal Bihari Vajpayee Medical University (ABVMU), Uttar Pradesh. 

On this, MLNMC authorities have confirmed that the change will apply to the batch of MBBS students who will graduate in the academic year 2025.

The decision has been taken to ensure a unified system of medical curriculum and examination in Uttar Pradesh as several medical colleges in the state are affiliated to ABVMU.

In this regard, speaking to HT, Dr Vatsala Mishra the Principal of MLNMC said, two years ago, MLNMC was affiliated with ABVMU and along with it the examinations are also conducted by the university. Therefore, from now onwards MBBS students will receive the degree certificates from ABVMU and along with MBBS students, MS and MD students will also get degrees from the new university as per their respective batches.

Till now the students of MLNMC have been receiving their degrees from King George’s Medical University (KGMU) since 2008, formerly known as Chhatrapati Shahuji Maharaj Medical University, Lucknow. However, MLNMC was affiliated with Allahabad University.

MLNMC admits 200 MBBS students every year, with 127 seats in 20 disciplines of postgraduate studies and 1 seat in one stream of super-specialisation studies in the medical college. After four annual examinations and an internship, the final degree is awarded by the university.

Motilal Nehru Medical College (MLNMC) was established in 1961 and is spread over 101 acres. The Medical College is a government medical college and hospital in Prayagraj, Uttar Pradesh, India. It was established in the memory of Motilal Nehru, the father of Jawaharlal Nehru. Every year the college admits a batch of 200 students into the first year of its MBBS degree course. Among these, 180 students are admitted through state counselling based on UP state rank in National Eligibility-Entrance Test (NEET) and 20 are admitted through all India counselling based on all India rank in NEET conducted by National Testing Agency (NTA).

Powered by WPeMatico

Emcure Pharma set to launch IPO on July 3

Emcure Pharmaceuticals, backed by Bain Capital, is set to float its Initial Public Offering (IPO) on July 3. The initial share sale will run until July 5, with bidding for anchor investors opening on July 2, as detailed in the Red Herring Prospectus (RHP).

The IPO includes a fresh issuance of equity shares totaling Rs 800 crore and an Offer for Sale (OFS) of 1.14 crore equity shares by promoters and existing shareholders.

According to PTI, those selling shares in the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital.
Currently, Satish Mehta holds a 41.85 per cent stake in the company and BC Investments owns a 13.07 per cent stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
The Pune-based firm Emcure Pharmaceuticals is engaged in developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Earlier this month, the company received Sebi’s go-ahead to float the initial share sale.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue. The equity shares of the company are expected to list on the BSE and NSE on July 10.

Powered by WPeMatico

Institute of Organ Transplantation to come up in Kozhikode at cost of Rs 558 crore

Thiruvananthapuram: The state government has allocated Rs 558.68 crore for establishing an Institute of Organ and Tissue Transplantation in Kozhikode.

According to Chief Minister Pinarayi Vijayan, this initiative aims to tackle the rampant exploitation in the organ transplant sector.

The state Cabinet, chaired by the Chief Minister on Wednesday, approved the Rs 558.68 crore project to be set up in Kozhikode.

According to a PTI report, “With an estimated investment of Rs 558.68 crore, this initiative promises an affordable alternative for organ transplants, reinforcing Kerala’s remarkable strides in public health and ensuring equitable access to advanced medical care for all,” Vijayan said in a post on X.   

He said the hospital will be established in two phases using KIIFB funds.   

Medical Dialogues team had earlier reported that Union Health Minister and Family Welfare Mansukh Mandaviya said that purchase of machines, availability of doctors and training will be ensured so that every medical college in the country could have the facility of organ transplant by the end of 2024. The Union Minister was addressing an organ donation pledge programme which was organised for the first time in the country in Agra on the occasion of the Prime Minister’s birthday. Union Minister of State for Health Prof SP Singh Baghel was also present on the occasion.  

Also Read:Health Ministry warns against commercial dealings in organ transplantation of foreigners, emphasizes awareness of transplant laws

Powered by WPeMatico

Hospital slapped Rs 6.54 Crore fine for Tampering with Medical Reports, Inflating Bills under PMJAY Scheme

Rajkot: A major scam in the Pradhan Mantri Jan Arogya Yojana (PMJAY) scheme recently came to light in Rajkot, where a paediatric hospital has been fined Rs 6.54 crore for committing irregularities under the scheme in the case of 116 patients.

According to a TOI report, the hospital allegedly tampered with medical reports and submitted inflated bills to the Health Department for its approval. The irregularities came to light during the investigation conducted by the Health Department.

The Health Department probe for over 45 days uncovered the irregularities conducted by the doctor, who runs the hospital located on Laxmi Nagar Main Road.

Also Read: No Age Cap: IRDAI directs insurers to offer Health Insurance to all Age Groups

As per the latest media report by the Times of India, the District Health Authority has informed that for these 116 patients, modified reports were sent for approval with a total claim amount of Rs 65.47 lakh. 

The District Health team started to probe the issue after detecting the anomalies. Standard Procedures require the doctors to send the lab reports and x-rays to justify the diagnosis of the patient. Under the PMJAY scheme, a patient can get up to Rs 10 lakh worth free treatment, with different packages for different types of diseases.

However, as per the officials, the doctor at the hospital admitted the children to the NICU for an extended period by tampering with the lab reports. This was done by the hospital to garner more funds.

To verify the records of 524 children, the Health Department team visited the laboratories, gathered the test reports and matched the same with the reports that the hospital had submitted for claims. Allegedly, the reports were manipulated on the computers at the hospital.

Taking note of these irregularities, the Health Department issued a penalty notice on Friday and asked the hospital to pay a fine of Rs 6.54 crore, ten times the claim amount of Rs 65.47 lakh.

Apart from this, the hospital has also been debarred from the PMJAY scheme and is also facing de-registration. Strict action might also be taken against the doctor, who may lose his licence to practise.

Commenting on the matter, the in-charge chief district health officer, Dr. P K Singh told TOI, “The hospital tampered with the lab reports and x-ray reports. A committee in Gandhinagar approves the package based on these reports. The hospital had admitted 524 children since July last year. We found evidence of irregularities in the case of 116 children during our investigation.”

Medical Dialogues had last month reported that taking action against the paedistrician involved who was accused of manipulating the reports of the newborns to extract a huge sum of money from the Government’s Ayushman Bharat Scheme, the State Health Department has expelled him from the Ayushman Card scheme of health insurance. The doctor running the hospital was accused of having admitted perfectly healthy children to the Intensive Care Unit (ICU) to fraudulently obtain funds from the Ayushman scheme.

Also Read: Ayushman Bharat Fraud: Rajkot Paediatrician expelled for manipulating reports, extracting Rs 2.53 crore

Powered by WPeMatico

CBI conducts searches at seven locations in Gujarat in NEET-UG paper leak case

In the latest update on the NEET case, the Central Bureau of Investigation (CBI) conducted searches at seven locations in Gujarat.

Speaking to PTI, the officials informed that the operation began in the morning at the premises of suspects spread across four districts — Anand, Kheda, Ahmedabad and Godhra.

The Central Bureau of Investigation (CBI) on Friday arrested the principal and the vice-principal of a school in Jharkhand’s Hazaribagh and a journalist of a Hindi newspaper in connection with the National-Eligibility-Entrance Test – Undergraduate (NEET-UG) paper leak, officials had said.

For more information click on the link below:

NEET Case Updates: CBI Conducts Searches At 7 Locations In Gujarat

Powered by WPeMatico

Study says low-salt diets linked to increased insulin resistance

In a study published in the Journal of Metabolic Health, researchers reviewed 23 clinical trials examining the effects of low-salt intake on glucose and insulin markers. Their findings suggested that reducing salt intake may have unintended negative effects, including increased insulin resistance, a significant risk factor for type 2 diabetes.

The analysis revealed that restricting salt consistently led to poorer blood sugar control and heightened insulin resistance. For instance, a moderate reduction in salt intake doubled fasting insulin levels in healthy young men within just one week. In patients with high blood pressure, an extreme low-salt diet significantly increased blood glucose and insulin spikes.

Reference:

James J. DiNicolantonio, James H. O’Keefe, et al,; Sodium restriction and insulin resistance: A review of 23 clinical trials; Journal of Metabolic Health

Powered by WPeMatico

CDSCO Panel Approves Roche’s Protocol Amendment Proposal To Study Inavolisib in combination with Phesgo

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Roche’s protocol amendment proposal for the clinical trial protocol titled “A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer.”

This came after the firm presented protocol amendment version 2.0 dated 30.01.2024 protocol no. WO44263.

This study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with placebo in combination with Phesgo, as maintenance therapy, after induction therapy in participants with previously untreated HER2-positive advanced breast cancer (ABC).

Inavolisib is an orally available inhibitor of phosphatidylinositol 3-kinase (PI3K), with potential antineoplastic activity. Inavolisib is a selective PI3K-p110α (PIK3CA) inhibitor, which may offer antineoplastic functionality. Therefore, it may serve as a new addition to combination therapy with conventional cancer treatment, such as chemotherapy.

Phesgo is a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer.

The mechanisms of action of Perjeta and Herceptin are believed to complement each other, as both bind to the HER2 receptor, but to different locations. The combination of Perjeta and Herceptin is thought to provide a more comprehensive, dual blockade of HER signalling pathways, thus preventing tumour cell growth and survival. The hyaluronidase in Phesgo temporarily and reversibly degrades hyaluronan, a gel-like substance that forms a barrier between cells under the skin, enabling Phesgo to be rapidly dispersed and absorbed over a greater area.

Phesgo offers faster administration of Perjeta and Herceptin under the skin in just minutes, compared to hours with standard IV administration. Phesgo can be administered by a healthcare professional in a treatment centre or at a patient’s home.

At the recent SEC meeting for oncology held on June 5 and 6, 2024, the expert panel reviewed the protocol amendment version 2.0 dated 30.01.2024 protocol no. WO44263 presented by the drug major Roche.

After detailed deliberation, the committee recommended the approval of the protocol amendment as presented by the firm.

Also Read:CDSCO Panel Rejects Roche Products India local Phase III CT waiver proposal for Atezolizumab injection SC route

Powered by WPeMatico

Film shooting at Angamaly Taluk Hospital: Kerala Human Rights Commission seeks explanation

Thiruvananthapuram: The State Human Rights Commission has taken suo moto cognizance of a controversy arising from a movie shoot in the emergency department of Angamaly Taluk Hospital in Ernakulam after many patients complained of inconvenience. 

The film, titled ‘Painkili’ and produced by Fahadh Faasil, began shooting at 9 PM at the hospital. 

According to an ANI report, the Human Rights Commission has demanded an explanation within seven days from those who granted permission for the shoot in the government hospital’s emergency department.

Also Read:On-duty doctor attacked at Nadapuram Taluk hospital, case registered

The Ernakulam District Medical Officer and Angamaly Taluk Hospital Superintendent have been directed to provide detailed reports.

According to the commission, the emergency room’s lights were dimmed, and restrictions were imposed during the shoot. Around 50 people, including actors, were present in the emergency room. Reports claim that the people who came with emergency medical problems could not even enter the premises because of the filming.

“It is understood that filming continued even as doctors were treating patients. The limited space in the emergency department exacerbated the situation. A person accompanying a critically ill patient was unable to enter the emergency department. Access through the main gate was blocked, and the crew instructed patients and bystanders to remain quiet during filming. The shoot has been ongoing for two days,” the commission said, news agency ANI reported.

Ruling out the allegation that treatment procedures at the hospital were affected, the superintendent of the hospital Dr Sunil J Elanthat said the shooting was held only in the reception area, and it did not affect the visitors of the hospital.”Hospital functioned normally, and the shooting procedures did not cause inconvenience to the visitors” he said, TOI reports

Health Minister Veena George has sought an explanation from the Director of the Health Department regarding the incident.

Powered by WPeMatico

Health Bulletin 29/ June/ 2024

Here are the top health stories for the day:

Cancelling NEET 2024 due to few misconducts unfair, 2 candidates file application before Supreme Court

Amid demands to cancel the National Eligibility-and-Entrance Test Undergraduate (NEET-UG) 2024 and hold a retest, two candidates from Meerut, scoring 705 and 690 respectively, argued that students who have prepared diligently should not be forced to retake the test.

They argued that holding a retest would be unfair and cause undue hardship to students and their families, noting that the NEET-UG is one of the toughest exams. The applicants stressed that the allegations of malpractice involve only a small number of students and that cancelling the entire process would be unjust to the majority who worked hard.

For more information, click on the link below:

Scrapping NEET 2024 For Mischief Of A Few Would Be Unjust: 2 Candidates File Application Before Supreme Court


NEET-UG paper leak: CBI conducts searches at seven locations in Gujarat

In the latest update on the NEET case, the Central Bureau of Investigation (CBI) conducted searches at seven locations in Gujarat.

Speaking to PTI, the officials informed that the operation began in the morning at the premises of suspects spread across four districts — Anand, Kheda, Ahmedabad and Godhra.

The Central Bureau of Investigation (CBI) on Friday arrested the principal and the vice-principal of a school in Jharkhand’s Hazaribagh and a journalist of a Hindi newspaper in connection with the National-Eligibility-Entrance Test – Undergraduate (NEET-UG) paper leak, officials had said.

For more information, click on the link below:

NEET Case Updates: CBI Conducts Searches At 7 Locations In Gujarat


TN CM letter to PM Modi: Requests for NEET exemption

Amid the raging row over the NEET controversy, the Tamil Nadu Assembly has unanimously passed a resolution against the National Eligibility and Entrance Test (NEET), urging the union government to scrap NEET and allow state governments to undertake medical admissions based on class 12 marks, as was done before NEET’s implementation.

The resolution was introduced by Tamil Nadu Chief Minister MK Stalin amid uproar over a paper leak in the NEET-UG 2024 examination and the sudden postponement of the NEET-PG 2024 examination.

For more information, click on the link below:

Tamil Nadu Assembly Unanimously Passes Resolution To Scrap NEET

Low-salt diets linked to increased insulin resistance, new study finds

In a study published in the Journal of Metabolic Health, researchers reviewed 23 clinical trials examining the effects of low-salt intake on glucose and insulin markers. Their findings suggested that reducing salt intake may have unintended negative effects, including increased insulin resistance, a significant risk factor for type 2 diabetes.

The analysis revealed that restricting salt consistently led to poorer blood sugar control and heightened insulin resistance. For instance, a moderate reduction in salt intake doubled fasting insulin levels in healthy young men within just one week. In patients with high blood pressure, an extreme low-salt diet significantly increased blood glucose and insulin spikes.

Reference: James J. DiNicolantonio, James H. O’Keefe, et al; Sodium restriction and insulin resistance: A review of 23 clinical trials; Journal of Metabolic Health

Powered by WPeMatico